Martinez-Vila C, Teixido C, Aya F, Martin R, Gonzalez-Navarro E, Alos L
Int J Mol Sci. 2025; 26(2).
PMID: 39859576
PMC: 11766255.
DOI: 10.3390/ijms26020861.
He Q, Shi X, Yan J, Wu M, Gu C, Yu X
Mol Clin Oncol. 2024; 20(4):29.
PMID: 38414510
PMC: 10895470.
DOI: 10.3892/mco.2024.2727.
Liang S, Wang H, Tian H, Xu Z, Wu M, Hua D
Front Immunol. 2023; 14:1249980.
PMID: 37753089
PMC: 10518408.
DOI: 10.3389/fimmu.2023.1249980.
Manzi J, Hoff C, Ferreira R, Glehn-Ponsirenas R, Selvaggi G, Tekin A
Cancers (Basel). 2023; 15(12).
PMID: 37370775
PMC: 10296050.
DOI: 10.3390/cancers15123165.
Prakash N, Pradeep G
J Oral Maxillofac Pathol. 2023; 26(3):300-306.
PMID: 36588829
PMC: 9802512.
DOI: 10.4103/jomfp.jomfp_338_22.
Utility of Cell-Free DNA Detection in Transplant Oncology.
Reddy T, Esmail A, Chang J, Ghobrial R, Abdelrahim M
Cancers (Basel). 2022; 14(3).
PMID: 35159010
PMC: 8833373.
DOI: 10.3390/cancers14030743.
Liquid Biopsy: A Distinctive Approach to the Diagnosis and Prognosis of Cancer.
Hirahata T, Quraish R, Quraish A, Ul Quraish S, Naz M, Razzaq M
Cancer Inform. 2022; 21:11769351221076062.
PMID: 35153470
PMC: 8832574.
DOI: 10.1177/11769351221076062.
Liquid Biopsy as a Tool for the Characterisation and Early Detection of the Field Cancerization Effect in Patients with Oral Cavity Carcinoma.
Perez-Ruiz E, Gutierrez V, Munoz M, Oliver J, Sanchez M, Galvez-Carvajal L
Biomedicines. 2021; 9(10).
PMID: 34680596
PMC: 8533108.
DOI: 10.3390/biomedicines9101478.
Diagnosis, biology and epidemiology of oligometastatic breast cancer.
Lacaze J, Aziza R, Chira C, De Maio E, Izar F, Jouve E
Breast. 2021; 59:144-156.
PMID: 34252822
PMC: 8441842.
DOI: 10.1016/j.breast.2021.06.010.
HPV ctDNA detection of high-risk HPV types during chemoradiotherapy for locally advanced cervical cancer.
Cabel L, Bonneau C, Bernard-Tessier A, Hequet D, Tran-Perennou C, Bataillon G
ESMO Open. 2021; 6(3):100154.
PMID: 34022731
PMC: 8164037.
DOI: 10.1016/j.esmoop.2021.100154.
Biomarkers for precision immunotherapy in the metastatic setting: hope or reality?.
Sajjadi E, Venetis K, Scatena C, Fusco N
Ecancermedicalscience. 2021; 14:1150.
PMID: 33574895
PMC: 7864694.
DOI: 10.3332/ecancer.2020.1150.
Circulating tumor DNA (ctDNA) detection is associated with shorter progression-free survival in advanced melanoma patients.
Marczynski G, Laus A, Dos Reis M, Reis R, de Lima Vazquez V
Sci Rep. 2020; 10(1):18682.
PMID: 33122747
PMC: 7596487.
DOI: 10.1038/s41598-020-75792-1.
Blood-based next-generation sequencing analysis of neuroendocrine neoplasms.
Zakka K, Nagy R, Drusbosky L, Akce M, Wu C, Alese O
Oncotarget. 2020; 11(19):1749-1757.
PMID: 32477464
PMC: 7233805.
DOI: 10.18632/oncotarget.27588.
Detection of ctDNA with Personalized Molecular Barcode NGS and Its Clinical Significance in Patients with Early Breast Cancer.
Yoshinami T, Kagara N, Motooka D, Nakamura S, Miyake T, Tanei T
Transl Oncol. 2020; 13(8):100787.
PMID: 32473569
PMC: 7260577.
DOI: 10.1016/j.tranon.2020.100787.
Blood-Based Next-Generation Sequencing Analysis of Appendiceal Cancers.
Shaib W, Zakka K, Staley 3rd C, Roberts A, Akce M, Wu C
Oncologist. 2019; 25(5):414-421.
PMID: 31784493
PMC: 7216457.
DOI: 10.1634/theoncologist.2019-0558.
Actionability of HER2-amplified circulating tumor cells in HER2-negative metastatic breast cancer: the CirCe T-DM1 trial.
Jacot W, Cottu P, Berger F, Dubot C, Venat-Bouvet L, Lortholary A
Breast Cancer Res. 2019; 21(1):121.
PMID: 31727113
PMC: 6854749.
DOI: 10.1186/s13058-019-1215-z.
Circulating Tumor Cells: State-of-the-art Update on Technologies and Clinical Applications.
Yap K, Cohen E, Reuben J, Khoury J
Curr Hematol Malig Rep. 2019; 14(5):353-357.
PMID: 31364034
DOI: 10.1007/s11899-019-00531-x.
Circulating Tumor Cells and Circulating Tumor DNA Detection in Potentially Resectable Metastatic Colorectal Cancer: A Prospective Ancillary Study to the Unicancer Prodige-14 Trial.
Bidard F, Kiavue N, Ychou M, Cabel L, Stern M, Madic J
Cells. 2019; 8(6).
PMID: 31142037
PMC: 6627974.
DOI: 10.3390/cells8060516.
Limited Sensitivity of Circulating Tumor DNA Detection by Droplet Digital PCR in Non-Metastatic Operable Gastric Cancer Patients.
Cabel L, Decraene C, Bieche I, Pierga J, Bennamoun M, Fuks D
Cancers (Basel). 2019; 11(3).
PMID: 30901876
PMC: 6468548.
DOI: 10.3390/cancers11030396.
Salivary Exosomes as Nanocarriers for Cancer Biomarker Delivery.
Cheng J, Nonaka T, Wong D
Materials (Basel). 2019; 12(4).
PMID: 30795593
PMC: 6416587.
DOI: 10.3390/ma12040654.
